ANSTO is a leading producer of medical radioisotopes that support accurate imaging, therapeutic planning, and targeted radiotherapy across the Asia–Pacific region. With world-class nuclear science capabilities and rigorous quality standards, ANSTO ensures a stable, reliable supply of diagnostic and therapeutic isotopes essential for managing complex cancers.Through Transmedic, ANSTO’s products reach cancer centres throughout Southeast Asia, strengthening continuity of care and enhancing the precision of radiation oncology workflows.